Not rendering correctly? View this email as a web page here.
            

Subject: Discontinuation of Seraseq® Lung + Brain CNV and Breast CNV products

Recommended Action: Transition to Seraseq® Solid Tumor CNV products


Dear Valued Customer,

We are issuing this notification to inform you that the products listed in Table 1 are being discontinued from our portfolio.

Table 1: Impacted Products

Material #

Description

Date of Discontinuation

0710-0411

Seraseq Breast CNV Mix, + 3 copies

15 August 2025

0710-0412

Seraseq Breast CNV Mix, + 6 copies

25 July 2025

0710-0413

Seraseq Breast CNV Mix, + 12 copies

15 August 2025

0710-0414

Seraseq Lung & Brain CNV Mix, + 3 copies

03 June 2025

0710-0415

Seraseq Lung & Brain CNV Mix, + 6 copies

15 August 2025

0710-0416

Seraseq Lung & Brain CNV Mix, + 12 copies

15 August 2025

As a part of our ongoing efforts to streamline and enhance our offerings, we are discontinuing these products following the consolidation of two product lines with the same copy number constructs into a single, more comprehensive product. The corresponding new products also include added content, offering superior value. Please refer to Table 2 for the corresponding replacement products.

Table 2: Replacement Products Available for Purchase

We will continue to fulfill orders of the legacy products until the official discontinuation date or until our inventory is depleted, whichever occurs first. Furthermore, we remain committed to supporting custom product requests as needed.

Thank you for your attention to this change. Please contact Customer Service at CDx-info@LGCgroup.com or your LGC sales representative if you have any questions.  

PK_pic

Sincerely,

Praveena Kamineni

LGC Clinical Diagnostics | Associate Product Manager, Oncology


FooterBar_WhiteonTeal_1700x400

Follow Us